An AI-powered app for diabetes prevention met CDC benchmarks for diabetes risk reduction at rates comparable to those in human-led programs, Baltimore-based Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health found.
The study included 368 participants with a median age 58, 71% of whom were female, 61% white, 27% Black and 6% Hispanic, according to an Oct. 27 news release. They were assigned either to one of four 12-month, remote, human-led programs or used a reinforcement learning algorithm app that delivered push notifications to facilitate weight management behaviors, physical activity and nutrition.
At the 12-month mark, 31.7% of participants in the fully AI-driven program and 31.9% of those in human-led programs met the CDC’s composite benchmark for diabetes risk reduction. The AI-paired group also had higher initiation and completion rates — 93.4% and 63.9%, respectively — compared to 82.7% and 50.3% in the human-led group.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
